Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 31.70
-0.43 (-1.34%)
May 19, 2026, 4:00 PM EDT
SHE:301246 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 253.09 | 117.63 | 51.47 | 87.17 | 434.8 | 493.85 |
Depreciation & Amortization | 202.49 | 202.49 | 178.6 | 156.88 | 89.8 | 80.36 |
Other Amortization | 2.69 | 2.69 | 3.39 | 4.44 | 6.14 | 5.52 |
Loss (Gain) From Sale of Assets | -0.77 | -0.77 | -0.53 | -0.57 | -14.44 | 0 |
Asset Writedown & Restructuring Costs | 49.05 | 49.05 | 0.27 | - | 1.97 | 7.88 |
Loss (Gain) From Sale of Investments | -30.1 | -30.1 | -5.24 | -20.99 | -169.14 | -190.23 |
Provision & Write-off of Bad Debts | - | - | 0.51 | -2.55 | 4.29 | 1.03 |
Other Operating Activities | -3.32 | 19.05 | 47.63 | 46.45 | 38.7 | 7.45 |
Change in Accounts Receivable | -579.11 | -579.11 | - | - | -494.66 | -289.98 |
Change in Inventory | -54.13 | -54.13 | -74.75 | 135.06 | -178.49 | -81.72 |
Change in Accounts Payable | 79.47 | 79.47 | -226.16 | -374.53 | 498.4 | 165.33 |
Change in Other Net Operating Assets | 11.08 | 11.08 | 8.62 | - | - | - |
Operating Cash Flow | -71.87 | -184.96 | -15.81 | 35.25 | 214.99 | 196.1 |
Operating Cash Flow Growth | - | - | - | -83.60% | 9.63% | 37.71% |
Capital Expenditures | -209.06 | -156.09 | -160.2 | -474.64 | -507.09 | -259.01 |
Sale of Property, Plant & Equipment | 2.53 | 2.11 | 1.36 | 1.14 | 104.26 | 1.33 |
Cash Acquisitions | - | - | -3.2 | - | - | - |
Investment in Securities | 48.83 | -86.65 | 575.55 | -1,596 | 33 | 0.01 |
Investing Cash Flow | -157.7 | -240.63 | 413.51 | -2,069 | -369.83 | -257.67 |
Long-Term Debt Issued | - | 504.55 | 51.14 | 21.25 | 494.5 | 110 |
Total Debt Issued | 467.93 | 504.55 | 51.14 | 21.25 | 494.5 | 110 |
Long-Term Debt Repaid | - | -307.91 | -66.9 | -98.28 | -55.07 | -188.85 |
Total Debt Repaid | -322.91 | -307.91 | -66.9 | -98.28 | -55.07 | -188.85 |
Net Debt Issued (Repaid) | 145.02 | 196.64 | -15.76 | -77.02 | 439.43 | -78.85 |
Issuance of Common Stock | - | - | - | 2,196 | - | - |
Repurchase of Common Stock | - | - | -32.8 | - | - | - |
Common Dividends Paid | -28.91 | -28.07 | -30.86 | -53.8 | -14.97 | -2.22 |
Dividends Paid | -28.91 | -28.07 | -30.86 | -53.8 | -14.97 | -2.22 |
Other Financing Activities | 6.17 | 62.78 | -97.48 | 88.07 | -134.32 | 15.27 |
Financing Cash Flow | 122.28 | 231.35 | -176.9 | 2,153 | 290.13 | -65.79 |
Foreign Exchange Rate Adjustments | -2.51 | -0.35 | 4.98 | 0.57 | 5.65 | -1.13 |
Net Cash Flow | -109.8 | -194.6 | 225.78 | 119.68 | 140.94 | -128.49 |
Free Cash Flow | -280.93 | -341.06 | -176.01 | -439.39 | -292.1 | -62.92 |
Free Cash Flow Margin | -12.71% | -17.59% | -9.94% | -21.38% | -14.15% | -3.99% |
Free Cash Flow Per Share | -0.71 | -0.86 | -0.44 | -1.13 | -0.83 | -0.18 |
Cash Income Tax Paid | 58.24 | 29.34 | -19.15 | 67.14 | 45.74 | 89.49 |
Levered Free Cash Flow | -16.78 | -428.53 | 187.98 | -511.52 | 120.97 | 53.49 |
Unlevered Free Cash Flow | -16.78 | -428.53 | 195.48 | -503.15 | 123.1 | 54.98 |
Change in Working Capital | -544.98 | -544.98 | -291.91 | -235.58 | -177.13 | -209.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.